IART vs. ATEC, ATRC, OFIX, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRG
Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry.
Integra LifeSciences vs. Its Competitors
Integra LifeSciences (NASDAQ:IART) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.
Integra LifeSciences presently has a consensus target price of $18.63, indicating a potential upside of 40.57%. Alphatec has a consensus target price of $17.89, indicating a potential upside of 63.67%. Given Alphatec's stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than Integra LifeSciences.
Integra LifeSciences has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 3.5% of Integra LifeSciences shares are owned by insiders. Comparatively, 22.8% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Integra LifeSciences has a net margin of -1.78% compared to Alphatec's net margin of -25.77%. Integra LifeSciences' return on equity of 12.12% beat Alphatec's return on equity.
Integra LifeSciences has higher revenue and earnings than Alphatec. Integra LifeSciences is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.
In the previous week, Alphatec had 3 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for Alphatec and 3 mentions for Integra LifeSciences. Alphatec's average media sentiment score of 0.92 beat Integra LifeSciences' score of 0.69 indicating that Alphatec is being referred to more favorably in the news media.
Summary
Integra LifeSciences and Alphatec tied by winning 8 of the 16 factors compared between the two stocks.
Get Integra LifeSciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Integra LifeSciences Competitors List
Related Companies and Tools
This page (NASDAQ:IART) was last updated on 7/1/2025 by MarketBeat.com Staff
